Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 September 2023 | Story Leonie Bolleurs | Photo Supplied
Prof Lesley Green
Prof Lesley Green was announced the winner of the 2023 ASSAf Humanities Book Award in the category ‘Established Researcher’. She delivered a lecture on her book: Rock. Water. Life: Ecology and Humanities for a Decolonial South Africa.

A group of more than 100 academics and students from universities across South Africa and abroad attended the virtual lecture by Prof Lesley Green, winner of the 2023 ASSAf Humanities Book Award in the category ‘Established Researcher’, who discussed her cross-cutting book, titled: Rock. Water. Life: Ecology and Humanities for a Decolonial South Africa. 

The lecture is part of a series focused on the Humanities Book Awards, offering award recipients a platform to discuss the motivation behind their books, the societal impact of their work, and the personal influences that shaped their text. Prof Reddy said that academics and students can anticipate a series of humanities book award lectures in the coming months. 

Prof Vasu Reddy, Deputy Vice-Chancellor: Research and Internationalisation at the University of the Free State (UFS), member of the Academy of Science of South Africa (ASSAf), and member of the Book Award adjudication panel, facilitated the recent (29 August 2023) online 2023 ASSAf Humanities Book Award Lecture. 

Prof Green, Professor of Anthropology and the Director of Environmental Humanities South (EHS) at the University of Cape Town, was announced the winner of the 2023 ASSAf Humanities Book Award in the category ‘Established Researcher’, for which ASSAf received 31 nominations. She received the award at the end of March this year during a ceremony at the Vineyard Hotel in Cape Town.

The first ASSAf Book Prize was awarded in 2017, and since then ASSAf has conferred the award on an individual every two years to recognise and celebrate the significance and impact of well-written scholarly writings on human knowledge and intellectual efforts in South Africa. 

Prof Reddy characterised Prof Green's specific work as an outstanding book that makes a formidable contribution to the field.

Justice-based environmental sciences 

Prof Green’s research centres on justice-based environmental sciences in South Africa, with a particular focus on the relationship between knowledge and democracy in the Global South – a central theme in her award-winning text.

In the three parts of her book, ‘Past Present’, ‘Present Futures’, and ‘Futures Imperfect’, Prof Green explores the interwoven nature of the past, present, and future. Within these three parts, she delves into the fascinating array of identity markers, inequality, racism, colonialism, and environmental destruction in South Africa. 

Prof Reddy noted that the text asserts a need for environmental research and governance to evolve, contributing to addressing South Africa’s deep history of racial oppression and environmental exploitation. “The book also offers an in-depth engagement of environmental conflict, shedding light on matters often overshadowed by daily concerns in contemporary South Africa,” he added. 

The book, linking the humanities and social sciences with the natural sciences and applied sciences, touched on an array of important topics, including the history of contested water access in Cape Town, struggles over fracking in the Karoo, the call for the decolonisation of science (#ScienceMustFall), land restitution versus the politics of soil, contests over baboon management, and the consequences of sending sewage to urban oceans. 

Prof Green has observed the landscape of environmentalism for a couple of years and noticed a series of struggles. “Typically, these conflicts were being presented in highly polemic ways, often showcasing tremendous tension between academic environmentalism and activists on the ground. I noticed recurring patterns – what was being presented as the preferred form of environmentalism was not something I could support. For example, the frack-free Karoo campaign. It left me quite uncomfortable due to the erasure of Khoi and San presence in the Karoo,” she added. 

“So, what kind of environmentalism could I get behind? Questions around a just environmental governance begin to arise for me.”

Property, #ScienceMustFall, and black environmentalism 

During the discussion, Prof Green shared particular images from each section of her book that caused her to pause and reconsider her stance on the type of environmentalism she could support.

“We inherited a way of thinking about the world that was separated from nature and society. We have challenged that division of nature and society in respect of race and racism and sex and sexism, but we have not brought that critique to bear on how we relate to the world. Somehow, under neo-liberal governance, we find ourselves in this space where economics and finance are seen as the hero that will bring it all together. 

These comments merely scratched the surface of Prof Green’s insights into her book – which Prof John Higgins, Emeritus Professor who formerly held the Arderne Chair in Literature at the University of Cape Town (now Senior Research Scholar at UCT), referred to in his closing remarks as a rich description of a magnificent book. According to him, this scholarly book not only circulates and makes knowledge public, but also provides an opportunity to question that very knowledge. 

This marked the first instance where ASSAf combined book selection with a discussion on the chosen book, underscoring the value of scholarly literature.

- In the Emerging Researcher category, Dr Rick de Villiers from the UFS Department of English was a shortlisted candidate for his book, titled: Eliot and Beckett’s Low Modernism: Humility and Humiliation. 

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept